Мировой рынок заменителей костной ткани – тенденции отрасли и прогноз до 2029 года

 Анализ и размер рынка заменителей костей

Согласно отчету CDC, ожидается, что глобальный уровень заболеваемости переломом шейки бедра увеличится на 240% у женщин и на 310% у мужчин. По оценкам, 200 миллионов женщин во всем мире страдают от остеопороза. Заболевания костей распространены среди пожилого населения из-за низкой плотности костной ткани. По оценкам, число американцев в возрасте 65 лет и старше в 2016 году составит около 46 миллионов, а к 2060 году их число вырастет до 98 миллионов. Рост заболеваемости заболеваниями опорно-двигательного аппарата и старение населения — это определенные факторы, которые привнесут новые инновации на рынок заменителей костной ткани.

По данным анализа Data Bridge Market Research, рынок заменителей костной ткани, объем которого в 2021 году составил 3 млрд долларов США, к 2029 году, как ожидается, достигнет 5,15 млрд долларов США при среднегодовом темпе роста 7% в прогнозируемый период с 2022 по 2029 год. Помимо информации о рыночных сценариях, таких как рыночная стоимость, темпы роста, сегментация, географический охват и основные игроки, рыночные отчеты, подготовленные Data Bridge Market Research, также включают в себя углубленный экспертный анализ, эпидемиологию пациентов, анализ конвейера, анализ цен и нормативную базу.

Объем и сегментация рынка заменителей костей      

Market Definition

A bone graft is an implantable material used to promote bone formation, bone healing, osseous reconstruction, and other procedures. These bone graft materials are used in bone grafting surgical procedures to replace defective or missing bone with these materials (bone graft). Although bone replacement had been practiced with various natural materials, it was rarely successful until the late nineteenth century. These substitutes can be derived from biological products such as demineralized bone matrix, platelet-rich plasma, hydroxyapatite, growth factor adjunction (such as bone morphogenetic protein), or synthetic products such as calcium sulphate, tricalcium phosphate ceramics, bioactive glasses, or polymer-based substitutes. All of these substitutes are not appropriate for every clinical application, and they must be chosen carefully based on their intended use.

Global Bone Substitutes Market Dynamics

Drivers

• Rising increasing incidence of trauma and accident cases

Osteoarthritis is one of the most common articular diseases in people over the age of 65. According to the Centers for Disease Control and Prevention (CDC), an estimated 63 million Americans have arthritis, with that number expected to rise to 78 million by 2040. Furthermore, according to World Population Prospects: The 2019 Revision Data, 1 in 11 people in 2019 were over the age of 65. This figure is expected to rise to one in every six people by 2050.

Furthermore, an increasing incidence of trauma and accident cases worldwide is regarded as one of the major factors likely to boost market demand. According to the National Safety Council, approximately 4.5 million people were severely injured in accidents in 2018. Thus, the above-mentioned factors, the bone substitutes market is expected to witness significant growth over the forecast period.

• Rising number of bone fracture cases

The increasing number of bone fracture cases, as well as the effectiveness of external bone growth stimulators in healing fractures, are driving up product demand. According to a study published in the Archives of Osteoporosis, 2020, fragility fractures accounted for 2.7 million in 2017 in the five largest European Union countries plus Sweden (EU6) and are expected to reach 3.3 million by 2030, a 23% increase from 2017. Furthermore, 14% of the Australian population has osteoporosis, according to a study published in the Orthopaedic Trauma Association International in 2020, and 60,000 hip fractures are expected to occur in Australia by 2050. This reflects the growing global fracture burden. As a result, there is an increasing demand for external bone growth stimulators, which will contribute to the growth of the industry.

Opportunities

• Rise in prevalence of orthopedic diseases

According to the Arthritis Foundation, degenerative joint disease disorders such as osteoarthritis will affect nearly 130 million people worldwide by 2050. The increased prevalence and burden of orthopaedic diseases has resulted in an increase in the patient pool undergoing minimally invasive surgeries worldwide. As a result, bone substitutes are in high demand. The high prevalence of bone marrow transplants and bone cancers increases the demand for bone substitutes.

Restraints/Challenges

• Limited medical reimbursement

Limited medical reimbursement for bone stimulation products and high treatment costs associated with BMP and PRP products will obstruct market growth, while side effects associated with BMP-based orthopaedic treatment will further challenge market growth during the forecast period.

This bone substitutes market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bone substitutes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Bone Substitutes Market

The COVID-19 had a negative impact on the bone substitutes market. Companies are facing a setback lockdown, which has caused disruptions in supply chain activities around the world. The worldwide implementation of lockdown restrictions has resulted in a decrease in patient visits. However, the situation is projected to improve as governments around the world begin to ease guidelines for resuming business activities. Furthermore, the demand for bone substitutes is expected to rise as elective surgeries and procedures resume in the near future.

Recent developments

• In November 2019, Stryker announced a definitive agreement to acquire Wright Medical Group. N.V. Wright Medical, which was founded in 1950, is a global medical device company that specialises in extremities and biologics.

Global Bone Substitutes Market Scope

The bone substitutes market is segmented on the basis of product, end user, and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Autotrans plantation
• Xenotrans plantation
• Allograft
• Demineralized Bone Matrix
• Others
• Synthetic
• Ceramics
• HAP
• β-TCP
• α-TCP
• Bi-phasic Calcium Phosphates (BCP)
• Others
• Composite
• Polymer
• Bone morphogenetic

End User

• Hospitals
• Specialty Clinics

 Application

• Spinal Fusion
• Joint Reconstruction
• Foot and Ankle
• Others

Bone Substitutes Market Regional Analysis/Insights

The bone substitutes market is analysed and market size insights and trends are provided by country, product, end user, and application as referenced above.

The countries covered in the bone substitutes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the bone growth stimulator market because of the high prevalence of osteoporosis or vertebral fractures in this area Companies are increasing the availability of electrical bone growth stimulators, which are useful after spinal fusion surgeries.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to rising number of road accidents and trauma cases in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The bone substitutes market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for bone substitutes market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the bone substitutes market. The data is available for historic period 2010-2020.

Competitive Landscape and Bone Substitutes Market Share Analysis

Конкурентная среда рынка заменителей костей содержит сведения по конкурентам. Включены сведения о компании, ее финансах, полученном доходе, рыночном потенциале, инвестициях в исследования и разработки, новых рыночных инициативах, глобальном присутствии, производственных площадках и объектах, производственных мощностях, сильных и слабых сторонах компании, запуске продукта, широте и широте продукта, доминировании в применении. Приведенные выше данные касаются только фокуса компаний на рынке заменителей костей.

Некоторые из основных игроков, работающих на рынке заменителей костной ткани:

• Zimmer Biomet (США)
• Биовентус (США)
• Synergy Orthopedics (США)
• Ito Co., Ltd. (Япония)
• Бостонская научная корпорация (США)
• BTL (Канада)
• Cyberonics, Inc. (США)
• DJO LLC (США)
• Medtronic (Ирландия)
• Nevro Corp (США)
• NeuroMetrix, Inc (США)
• Эбботт (США)
• Uroplasty Inc (США)
• Cogentix Medical (США)
• Aleva Neurotherapeutics (Швейцария)
• NeuroPace Inc (США)
• AxioBionics (США)
• Beurer GmbH (Германия)
• Omron Healthcare, Inc (Япония)
• RS Medical (Япония)
• Страйкер (США)

SKU-56384